Results 131 to 140 of about 98,812 (291)

Extracellular Vesicles miRNome Profiling Reveals miRNAs Engagement in Dysfunctional Lipid Metabolism, Chronic Inflammation and Liver Damage in Subjects With Metabolic Dysfunction‐Associated Steatotic Liver Disease

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
This study explores the association between the miRNome profile of circulating extracellular vesicles and metabolic dysfunction, liver inflammation, and damage in patients with metabolic MASLD, identifying key miRNAs (miR‐122‐5p, miR‐375‐3p, let‐7d‐5p, and let‐7f‐5p) that modulate lipid metabolism and inflammatory pathways in ‘at‐risk MASH’ patients ...
Gian Paolo Caviglia   +14 more
wiley   +1 more source

Hypertriglyceridemia-induced recurrent acute pancreatitis: A case-based review

open access: yesIndian Journal of Endocrinology and Metabolism, 2012
Hypertriglyceridemia is a rare, but well-known cause of acute pancreatitis. A serum triglyceride level of more than 1000 to 2000 mg / dl is the identifiable risk factor.
Sunil K Kota   +4 more
doaj   +1 more source

Role for the liver X receptor agonist 22‐ketositosterol in preventing disease progression in an Alzheimer's disease mouse model

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose Liver X receptors (LXRs) are promising therapeutic targets for alleviating Alzheimer's disease (AD) symptoms. We assessed the impact of the semi‐synthetic LXR agonist 22‐ketositosterol on disease progression in an AD mouse model.
Nikita Martens   +15 more
wiley   +1 more source

Hypertriglyceridemia in Gout [PDF]

open access: bronze, 1964
Elaine B. Feldman, Stanley L. Wallace
openalex   +1 more source

Significantly different clinical features between hypertriglyceridemia and biliary acute pancreatitis: a retrospective study of 730 patients from a tertiary center

open access: yesBMC Gastroenterology, 2018
BackgroundUnlike western world, gallstones and hypertriglyceridemia (HTG) are among the first two etiologies of acute pancreatitis (AP) in China. But yet, detailed differences in clinical features and outcomes between hypertriglyceridemia and biliary ...
Xiaoyao Li   +8 more
semanticscholar   +1 more source

Pyrotinib and Nab‐Paclitaxel in HER2‐Positive Breast Cancer (PANHER Trial): A Prospective, Single‐Arm, Phase II Trial

open access: yesCancer Science, EarlyView.
In this multicenter, single‐arm, open‐label phase II trial, patients with HER2‐positive breast cancer who had previously received chemotherapy with taxanes or anthracyclines were enrolled to receive pyrotinib combined with nab‐paclitaxel, and the results demonstrated promising efficacy with an acceptable safety profile.
Huan Li   +23 more
wiley   +1 more source

Laparoscopic bariatric surgery for the treatment of severe hypertriglyceridemia

open access: yesAsian Journal of Surgery, 2015
Background: It is well established that severe hypertriglyceridemia can lead to pancreatitis. At present, medical treatment for patients with severe hypertriglyceridemia and repeat pancreatitis attacks is not adequate. The aim of this study was to assess
Sung-Yu Hsu   +4 more
doaj   +1 more source

Control of 3-Hydroxy-3-Methylglutaryl-CoA Reductase Activity in Cultured Human Fibroblasts by Very Low Density Lipoproteins of Subjects with Hypertriglyceridemia [PDF]

open access: bronze, 1978
Sandra H. Gianturco   +7 more
openalex   +1 more source

Hypertriglyceridemia-Related Pancreatitis In Patients With Type 2 Diabetes: Links And Risks

open access: yesDiabetes, Metabolic Syndrome and Obesity : Targets and Therapy, 2019
Disturbances in glucose and lipid homeostasis are cardinal features of the metabolic syndrome that affect millions of people worldwide. These conditions have multi-organ impact, and while cardiovascular effects are usually the core for studies and ...
E. Shemesh, B. Zafrir
semanticscholar   +1 more source

Association between remnant cholesterol and chronic kidney disease: Systematic review and meta‐analysis

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 5, Page 2573-2583, May 2025.
Abstract Background and Aims Adequate lipid control has emerged as a key factor in the prevention and management of chronic kidney disease (CKD). Remnant cholesterol (RC), a lipoprotein with an established association with cardiovascular risk, has been investigated in the context of CKD.
Paschalis Karakasis   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy